9c

 

65C-3883

37

 

 

Table 5. Summary and Statistical Analysis of Uterine Contents (continued)

 

 

322U66 HCl (mg/kg/day, po)

 

0

75

150

300

300a

No. Adversely Affected Implants per Litterce

 

2.24

1.85

2.15

2.08

2.58

 

±0.52

±0.44

±0.46

±0.45

±0.51

 

N=29

N=27

N=27

N=25

N=24

Percent Adversely Affected Implants per Litterce

 

13.67

13.88

13.02

13.51

17.92

 

±3.15

±3.46

±2.76

±3.04

±3.29

 

N=29

N=27

N=27

N=25

N=24

No Litters with Adversely Affected Implantse

 

18

16

20

19

18

% Litters with Adversely Affected Implantse

 

62.07

59.26

74.07

76.00

75.00

 

 

 

 

 

 

Live Littersf

29

27

27

25

24

No. Live Fetuses per Litterc

 

15.28

11.22

15.62

15.04

14.00

 

±0.53

±0.78

±0.28

±0.62

±0.63

 

N=29

N=27

N=27

N=25

N=24

Percent Males Fetuses per Litterc

 

57.06

51.44

49.31

47.74

54.98

 

±2.68

±3.23

±2.76

±2.54

±2.66

 

N=29

N=27

N=27

N=25

N=24

No. Male Fetuses per Litterc

 

8.72

6.96

7.63

7.12

7.71

 

±0.51

±0.48

±0.43

±0.45

±0.52

 

N=29

N=27

N=27

N=25

N=24

No. Females per Literc

 

6.77

7.26

7.89

7.92

6.29

 

±0.47

±0.61

±0.46

±0.50

±0.46

 

N=29

N=27

N=27

N=25

N=24

 

(continued)

 

 

 

 

 


Back a Page
Next Page
Back to Wellbutrin SR® NDA Index Page
Back to Main Index

1